Abstract
Glucocorticoids (GCs) are potent anti-inflammatory drugs. A new study by Auger et al. found that GCs increase itaconate, an anti-inflammatory tricarboxylic acid (TCA) cycle intermediate, by promoting movement of cytosolic pyruvate dehydrogenase (PDH) to mitochondria. Itaconate was sufficient for mediating the anti-inflammatory effects of GCs in mice, overriding the notion that nuclear glucocorticoid receptor (GR) is necessary for inflammation inhibition.
Original language | English |
---|---|
Journal | Trends in Endocrinology and Metabolism |
DOIs | |
State | Accepted/In press - 2024 |
Bibliographical note
Publisher Copyright:© 2024 Elsevier Ltd
Keywords
- GR
- LPS
- PDH
- itaconate
- macrophage